Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
ElsMed

Hepatic Function SPECT Testing Before and During Radiotherapy Can Help in Treatment Planning for Liver Cancer Patients

By Medimaging International staff writers
Posted on 26 Feb 2013
Monitoring the hepatic function of unresectable liver cancer patients evaluated by 99mTc-labeled iminodiacetic acid (HIDA) used with single-photon emission computed tomography (SPECT) imaging before and during radiation therapy provides critical data that could guide more customized treatment plans and reduce risks of liver injury, according to recent research.

The study’s findings were presented at the 2013 Cancer Imaging and Radiation Therapy Symposium, held February 8–9, 2013, in Orlando (FL, USA). This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO; Fairfax, VA, USA) and the Radiological Society of North American (RSNA; Oak Brook, IL, USA). This research included 14 patients who had unresectable intrahepatic tumors and were treated with three-dimensional conformal radiation therapy (3D CRT), intensity-modulated radiation therapy (IMRT) or stereotactic body radiation therapy (SBRT) at a median dose of 52 Gy. Patients underwent HIDA SPECT scanning prior to radiation therapy, after delivery of 50%–60% of the planned doses and one month after completion of radiation therapy. Moreover, indocyanine green tests, a measure of overall liver function, were performed +/- one day of each SPECT scan. The 27 dynamic HIDA SPECT volumes were captured over a 60-minute period after the administration of 10 mCi 99mTc-labeled HIDA on a SPECT/CT scanner.

Gauging the regional liver function prior to radiation therapy allows assessment of the precondition of the patient’s liver function. Assessing the change of the regional liver function during the mid-course of radiation therapy indicates the response of the individual patient’s liver to radiation doses. Integrating the planned radiation doses with the regional liver function evaluation and reassessment, the researchers devised a model to predict the regional liver function postradiation therapy. This information is key to providing patients with the optimal radiation doses for better tumor control, while minimizing the risk for each patient.

“Through this assessment method, patients could potentially receive more treatment doses tailored to meet their needs, based on their liver function,” said Hesheng Wang, PhD, the lead study author and a postdoctoral fellow in radiation oncology at the University of Michigan in (Ann Arbor, MI, USA). “The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing.”

Related Links:

University of Michigan



Channels

Radiography

view channel
Image: GE Healthcare’s Revolution EVO CT system (Photo courtesy of GE Healthcare).

CT System Improves Outcomes While Supporting Wide Range of Patients

New computed tomography (CT) technology can improve patient outcomes while cutting the cost of providing care. Revolution EVO, developed by GE Healthcare (Chalfont St. Giles, UK), is designed to support... Read more

MRI

view channel
Image: In a preterm infant’s brain, an MRI scan can reveal abnormalities that were undetected by previous methods. The scans on the left show normal gray matter, while those on the right show abnormal gray matter (Photo courtesy of Washington University in St. Louis).

MRI Tracks Infant Brain Growth in First Months of Life

For the first time, researchers have used magnetic resonance imaging (MRI) of the newborn brain to calculate the volume of multiple brain regions and to map out regional growth trajectories during the... Read more

Ultrasound

view channel
Image: UAMS researcher William Culp, MD, (right), and Doug Wilson of UALR (left) have developed a device to treat stroke (Photo courtesy of UAMS/UALR Office of Communications).

Clot-Buster Ultrasound Device May Become Best Treatment Option for Stroke Patients

A new device is being developed to treat stroke more effectively. The new technology fits on the head similar to a halo and delivers therapy to rapidly bust clots that cause stroke. The device was developed... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.